Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Peripheral Nervous System Diseases

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Peripheral Nervous System Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldari, S; De Luca, G; Di Leo, R; Girlanda, P; Mazzeo, A; Rodolico, C; Toscano, A; Vita, G1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Peripheral Nervous System Diseases

ArticleYear
Peripheral neuropathy as the presenting feature of multiple system atrophy.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2001, Volume: 11, Issue:2

    Topics: Autonomic Nervous System; Benzamides; Contrast Media; Fatal Outcome; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Fibers, Myelinated; Peripheral Nervous System Diseases; Pyrrolidines; Tomography, Emission-Computed, Single-Photon

2001